mammography screening program
Recently Published Documents


TOTAL DOCUMENTS

78
(FIVE YEARS 2)

H-INDEX

16
(FIVE YEARS 0)

2021 ◽  
Vol 41 (5) ◽  
pp. 257-267
Author(s):  
Hanaa Abdulla Alkhawari ◽  
Akram Mahmoud Asbeutah ◽  
Abdullah Abdulaziz Almajran ◽  
Latifa Abdullah AlKandari

BACKGROUND: Breast cancer is the most common malignancy among women in Kuwait, representing 39.8% of all female cancer cases. OBJECTIVES: Report the data of the Kuwait National Mammography Screening Program (KNMSP) for a 5-year period. DESIGN: Prospective data collection. SETTING: Population-based screening. SUBJECTS AND METHODS: We included mammography screens done for Kuwaiti women (age 40 years and older) who attended the KNMSP from 2014 to 2019 to screen for breast cancer. A full-field digital mammography system was used to acquire the mammographic images in craniocaudal and mediolateral oblique projections. Independent double-blind reading of the mammograms was performed by two radiologists. MAIN OUTCOME MEASURE: Early detection of breast cancer. SAMPLE SIZE: 14 773 asymptomatic women met inclusion criteria (mean [SD] age, 51.8 (8.2). RESULTS: Lesions were detected in 551 women (3.7%). These included 233 malignant lesions (233/551, 42.3%), 57 high-risk lesions (10.3%) and 261 benign lesions (47.4%). The participation rate was 7.8% of the target population of women 40–69 years of age. The majority of breast cancer cases were reported in the age group 45–49 years (23.2%). The KNMSP study recall rate for 5 consecutive years was in a range of 11.9–16.5% (mean, 14.3%). The detection rate of ductal/lobular carcinoma in situ and invasive breast cancer were 2.5 and 13.6 per 1000 screened women, respectively. Invasive ductal carcinoma was the most common type. Only 4314 women followed up within 12–15 months of the first mammography for a retention rate of 29.2%. CONCLUSIONS: Screening mammography improves early detection of breast cancer in women older than 40 years but poor participation is a limitation. We are aiming to increase the participation rate to 70% of the population. LIMITATIONS: Lack of participation by women. CONFLICT OF INTEREST: None.


2020 ◽  
Vol 28 (2) ◽  
pp. 20-28
Author(s):  
Laura Steponavičienė ◽  
Rūta Briedienė ◽  
Rasa Vansevičiūtė-Petkevičienė ◽  
Daiva Gudavičienė ◽  
Ieva Vincerževskienė

BackgroundBreast cancer is the most frequent oncological disease as well as the leading cause of cancer death among women worldwide. Decline in mortality in economically strong countries is observed. This decline is mostly related to early diagnosis (improvement in breast cancer awareness and mammography screening program (MSP)) and more effective treatment. In the end of 2005, the MSP started in Lithuania. The main aim of this article was to evaluate breast cancer mortality during 22 years in Lithuania, as well as changes before the start of the MSP and during its implementation, in order to assess the influence of the MSP on mortality. Materials and MethodsAnalysis was based on data from the population-based Lithuanian Cancer Registry. Analysis of changes in mortality included the period from 1998 to 2019. Age standardized mortality rates were calculated for assessment of changes. Join-point regression analysis was used. ResultsApplying the segmental regression model, it was found that during the study period mortality was statistically significantly decreasing by -1.1% each year.  Mortality among women under the age of 50 decreased both before and during the implementation of MSP. Mortality in the target population also was already decreasing until the implementation of the program, but since 2006 significant reduction in mortality was observed in this group. ConclusionsOverall breast cancer mortality is decreasing in Lithuania. After the implementation of MSP the largest reduction in mortality was observed among the target population, however, it is not as pronounced as it could be with the well-organized MSP.


2020 ◽  
Vol Volume 12 ◽  
pp. 509-518
Author(s):  
Jakob H Viuff ◽  
Ilse Vejborg ◽  
Walter Schwartz ◽  
Martin Bak ◽  
Ellen M Mikkelsen

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Laura Khil ◽  
Jan Heidrich ◽  
Ina Wellmann ◽  
Vanessa Kääb-Sanyal ◽  
Stefanie Weigel ◽  
...  

2019 ◽  
Vol 34 (12) ◽  
pp. 1143-1150 ◽  
Author(s):  
Pietro Trocchi ◽  
Oliver Kuss ◽  
Vanessa Kääb-Sanyal ◽  
Oliver Heidinger ◽  
Andreas Stang

Sign in / Sign up

Export Citation Format

Share Document